VeriMomVeriMom
HIGH RISK

임신 중 thiabendazole을 피해야 할까요? | VeriMom

Thiabendazole has an EU harmonised classification that includes reproductive toxicity H360 (Category 1B / H360FD in CLP listings), which meets criteria for confirmed reproductive hazard. ECHA/CLP documents and the EU delegated regulation list H360 for thiabendazole, and multiple developmental/reproductive animal studies (rats, mice, rabbits) and JECFA/WHO monographs report fetal and developmental effects at toxic doses, supporting demonstrable mechanism(s) of developmental toxicity and systemic distribution. Sources: ECHA substance/factsheet and EU CLP entry; peer-reviewed developmental studies and JECFA monographs.

ECHA regulatory hazard statements

  • H400
  • H410

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

thiabendazole은 임신 중 안전한가요?
Thiabendazole has an EU harmonised classification that includes reproductive toxicity H360 (Category 1B / H360FD in CLP listings), which meets criteria for confirmed reproductive hazard. ECHA/CLP documents and the EU delegated regulation list H360 for thiabendazole, and multiple developmental/reproductive animal studies (rats, mice, rabbits) and JECFA/WHO monographs report fetal and developmental effects at toxic doses, supporting demonstrable mechanism(s) of developmental toxicity and systemic distribution. Sources: ECHA substance/factsheet and EU CLP entry; peer-reviewed developmental studies and JECFA monographs.
thiabendazole은 모유 수유 중 안전한가요?
Because of the harmonised H360 classification and animal/peer-reviewed data showing systemic absorption and distribution (including to fetal tissues) and developmental effects, thiabendazole is flagged for reproductive/developmental hazard that is relevant to lactation exposure. Human/animal ADME data show rapid absorption and systemic distribution; lactational transfer is plausible though milk-specific data are limited, so exposure to breastfed infants is considered low but measurable from systemic maternal exposure.
thiabendazole은 아기 피부에 안전한가요?
Hazard and mechanism are not increased for infants absent infant‑specific hazard evidence, but the harmonised H360 classification and animal developmental findings indicate a high reproductive/developmental hazard. Dermal/topical exposure on baby skin is assigned a higher exposure score (+1) because infant skin has higher surface-area-to-weight and an immature barrier and thiabendazole has measurable systemic absorption in ADME studies, so topical use could give measurable systemic exposure in infants.
VeriMom은 thiabendazole을 어떻게 평가하나요?
VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 thiabendazole을 20/100 (높은 위험)로 평가합니다.
임신 중 thiabendazole 대체 안전 성분은?
유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.

모든 성분표를 2초 만에 확인

VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.

의료 면책 조항

이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.

VeriMom 앱에서 모든 기능을 이용해 보세요